Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-21-051864
Filing Date
2021-04-19
Accepted
2021-04-19 14:09:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm212636d3_defa14a.htm DEFA14A 22764
2 GRAPHIC tm212636d3_defa14aimg001.jpg GRAPHIC 560330
3 GRAPHIC tm212636d3_defa14aimg002.jpg GRAPHIC 428382
  Complete submission text file 0001104659-21-051864.txt   1385750
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39202 | Film No.: 21834027
SIC: 2834 Pharmaceutical Preparations